Spotify 
Apple Podcasts 
Amazon Music The introduction of an mRNA seasonal flu vaccine is creating new questions for public health communicators about vaccine hesitancy, misinformation, and how to build confidence in vaccination. Jessica Malaty Rivera, executive director of the Infodemiology Initiative at Public Good Projects, discusses the questions and concerns emerging around the new mRNA flu vaccine, including how existing doubts about mRNA vaccines may be influencing perceptions of flu vaccination. She explains why communicators should focus on providing clear information about who the vaccine is for, what people can expect, and what is known about its safety and side effects rather than trying to respond to every circulating false claim. Rivera also discusses communication strategies such as pre-bunking and the “truth sandwich,” and how public health agencies can encourage questions and curiosity while keeping evidence-based information at the center of the conversation.
First mRNA flu vaccine brings COVID-era concerns into flu vaccine conversations | Infodemiology.com
Power Hour PLUS: Expand Your Impact | ASTHO
Power Hour PLUS: Expand Your Impact - Session 1 - From Urgency to Action: Advancing Decision-Making
ASTHO Welcomes Lindsey Myers, Jane Bigham, and Jeffrey Ekoma to New Leadership Roles | ASTHO
